source
- Bristol Myers reaches a crossroads as a make-or-break year takes shapeBristol Myers Squibb is facing a bit of an identity crisis. CEO Chris Boerner is nearly two and a half years into his tenure, with most of his time defined byEndpoints · 3mo ago↗ source
- Pfizer earns positive Phase 3 in multiple myeloma; ICON overstated revenuePfizer’s positive Phase 3 data in multiple myeloma: The company’s Elrexfio produced a “statistically significant and clinically meaningful improvement” in progression-free survival in patients with…Endpoints · 3mo ago↗ source
- Infant formula largely safe from heavy metals, FDA findsFDA sampled 312 major infant formula brands and found low or undetectable levels of pesticide residue, PFAS, heavy metals and phthalates.STAT